Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments. research hub

ABATACEPT VERSUS TOCILIZUMAB BY SUBCUTANEOUS ADMINISTRATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN TARGETED TREATMENT INADEQUATE RESPONDER PATIENTS: A RANDOMIZED, OPENLABELED, SUPERIORITY TRIAL. -SUNSTAR-

This study compares two common medicines, Orencia and RoActemra, for adults with rheumatoid arthritis whose current treatments aren't working well enough. We want to see which one works better at reducing disease activity over six months.